DeMane F. Michael's most recent trade in Nevro Corp was a trade of 7,056 Common Stock done . Disclosure was reported to the exchange on Dec. 31, 2024.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Nevro Corp | DeMane F. Michael | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Dec 2024 | 7,056 | 61,863 (0%) | 0% | 0 | Common Stock | |
| Nevro Corp | Michael F. DeMane | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Sep 2024 | 4,695 | 54,807 (0%) | 0% | 0 | Common Stock | |
| Nevro Corp | Michael F. DeMane | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jun 2024 | 3,117 | 50,112 (0%) | 0% | 0 | Common Stock | |
| Nevro Corp | Michael F. DeMane | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 May 2024 | 19,169 | 46,995 (0%) | 0% | 0 | Common Stock | |
| Nevro Corp | Michael F. DeMane | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Mar 2024 | 1,817 | 33,205 (0%) | 0% | 0 | Common Stock | |
| Nevro Corp | Michael F. DeMane | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Sep 2023 | 1,365 | 30,169 (0%) | 0% | 0 | Common Stock | |
| Nevro Corp | Michael F. DeMane | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jun 2023 | 1,032 | 28,804 (0%) | 0% | 0 | Common Stock | |
| Nevro Corp | Michael F. DeMane | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 07 Jun 2023 | 80,000 | 27,772 (0%) | 0% | 0 | Common Stock | |
| Nevro Corp | Michael F. DeMane | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 May 2023 | 6,754 | 107,772 (0%) | 0% | 0 | Common Stock | |
| Nevro Corp | Michael F. DeMane | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 18.00 per share. | 12 Apr 2023 | 80,291 | 101,018 (0%) | 0% | 18 | 1,445,238 | Common Stock |
| Nevro Corp | Michael F. DeMane | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Apr 2023 | 80,291 | 0 | - | - | Stock Option (Right to Buy) | |
| Nevro Corp | Michael F. DeMane | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Mar 2023 | 726 | 20,727 (0%) | 0% | 0 | Common Stock | |
| Nevro Corp | Michael F. DeMane | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Dec 2022 | 662 | 20,001 (0%) | 0% | 0 | Common Stock | |
| Nevro Corp | Michael F. DeMane | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Sep 2022 | 563 | 19,339 (0%) | 0% | 0 | Common Stock | |
| Nevro Corp | Michael F. DeMane | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jun 2022 | 598 | 44,900 (0%) | 0% | 0 | Common Stock | |
| Nevro Corp | Michael F. DeMane | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 May 2022 | 4,155 | 44,302 (0%) | 0% | 0 | Common Stock | |
| Nevro Corp | Michael F. DeMane | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Mar 2022 | 362 | 40,147 (0%) | 0% | 0 | Common Stock | |
| Nevro Corp | Michael F. DeMane | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Sep 2021 | 225 | 231,660 (0%) | 0% | 0 | Common Stock | |
| Nevro Corp | Michael F. DeMane | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jun 2021 | 158 | 231,435 (0%) | 0% | 0 | Common Stock | |
| Nevro Corp | Michael F. DeMane | Director | Sale of securities on an exchange or to another person at price $ 179.03 per share. | 22 Jun 2021 | 6,445 | 231,277 (0%) | 0% | 179.0 | 1,153,837 | Common Stock |
| Nevro Corp | Michael F. DeMane | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 May 2021 | 1,167 | 237,722 (0%) | 0% | 0 | Common Stock | |
| Nevro Corp | Michael F. DeMane | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Mar 2021 | 188 | 236,555 (0%) | 0% | 0 | Common Stock |